21 – 25 of 86
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts
(
- Contribution to journal › Article
-
Mark
Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survival
(
- Contribution to journal › Scientific review
- 2013
-
Mark
What's in the Black Box of Arthritis Rehabilitation? A Comparison of Rehabilitation Practice for Patients with Inflammatory Arthritis in Northern Europe
(
- Contribution to journal › Article
-
Mark
Characterization of nitrotyrosine as a biomarker for arthritis and joint injury
(
- Contribution to journal › Article
-
Mark
The Comparison of Trial Data-Based and Registry Data-Based Cost-Effectiveness of Infliximab Treatment for Rheumatoid Arthritis in Sweden Using a Modeling Approach
(
- Contribution to journal › Article